Literature DB >> 7241435

Simple instructions for using pressurized aerosol bronchodilators.

S P Newman, D Pavia, S W Clarke.   

Abstract

Although the manufacturers of pressurized aerosol bonchodilators issue instructions for using the inhalers, little or no experimental verification exists. Bronchodilatation has been measured after controlled inhalations of 500 μg terbutaline sulphate given in a systematic series of investigations to 8 patients with reversible airways obstruction at 2 different inhalation flow rates (25 1/min and 80 1/min), 3 different lung volumes (20%, 50% and 80% vital capacity) and followed by 2 different breath-holding pauses (4 and 10 seconds). The results indicate that patients may release the aerosol at any time during the course of a slow deep inhalation which should be followed by 10 seconds of breath-holding. This will ensure an optimal bronchodilator response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7241435      PMCID: PMC1437930          DOI: 10.1177/014107688007301105

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  11 in total

1.  Use of pressurised aerosols by asthmatic patients.

Authors:  I C Paterson; G K Crompton
Journal:  Br Med J       Date:  1976-01-10

2.  Evaluation of a breath actuated pressurized aerosol.

Authors:  T J Coady; H J Davies; P Barnes
Journal:  Clin Allergy       Date:  1976-01

3.  The response of asthmatic subjects to isoproterenol inhaled at differing lung volumes.

Authors:  D J Riley; B W Weitz; N H Edelman
Journal:  Am Rev Respir Dis       Date:  1976-09

4.  Deposition of aerosols in pulmonary disease.

Authors:  I S Goldberg; R V Lourenço
Journal:  Arch Intern Med       Date:  1973-01

5.  Diseases of the respiratory system. Asthma.

Authors:  G M Sterling
Journal:  Br Med J       Date:  1978-05-13

6.  Distribution of bronchodilatation in normal subjects: beta agonist versus atropine.

Authors:  M J Hensley; C F O'Cain; E R McFadden; R H Ingram
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-11

Review 7.  Aerosol therapy in acute and chronic respiratory disease.

Authors:  W F Miller
Journal:  Arch Intern Med       Date:  1973-01

8.  Misuse of pressurised nebulisers.

Authors:  J E Earis; A Bernstein
Journal:  Br Med J       Date:  1978-06-10

9.  Correct use of aerosol inhalers.

Authors:  J R Grainger
Journal:  Can Med Assoc J       Date:  1977-03-19       Impact factor: 8.262

10.  Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.

Authors:  D Pavia; M L Thomson; S W Clarke; H S Shannon
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

View more
  18 in total

1.  The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.

Authors:  Hugh D C Smyth; Vance P Beck; Dennis Williams; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2004-02-10       Impact factor: 3.246

2.  Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.

Authors:  Rajoshi Biswas; Nicola A Hanania; Ashutosh Sabharwal
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-02-03       Impact factor: 2.849

3.  Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes.

Authors:  T Engel; B Scharling; B Skovsted; J H Heinig
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

4.  Beta-adrenoceptor responses to inhaled salbutamol in normal subjects.

Authors:  B J Lipworth; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.

Authors:  B J Lipworth; D G McDevitt; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

6.  Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

7.  Pressurised metered dose inhaler-spacer technique in young children improves with video instruction.

Authors:  Nicole Shaw; Peter Le Souëf; Lidija Turkovic; Lucy McCahon; Anthony Kicic; Peter D Sly; Sunalene Devadason; André Schultz
Journal:  Eur J Pediatr       Date:  2016-06-01       Impact factor: 3.183

8.  Comparison of two chamber devices in patients using a metered-dose inhaler with satisfactory technique.

Authors:  H D Fuller
Journal:  CMAJ       Date:  1986-09-15       Impact factor: 8.262

Review 9.  Standards for bioequivalence of inhaled products.

Authors:  H Chrystyn
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

10.  The biochemical effects of high-dose inhaled salbutamol in patients with asthma.

Authors:  B J Lipworth; R A Clark; C G Fraser; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.